- Report
- April 2025
- 207 Pages
Global
From €2190EUR$2,500USD£1,900GBP
- Report
- January 2026
- 191 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 185 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- February 2026
- 382 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- October 2025
- 150 Pages
Global
From €3372EUR$3,850USD£2,927GBP
€4248EUR$4,850USD£3,687GBP
- Report
- January 2026
- 183 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- October 2025
- 92 Pages
Global
From €4248EUR$4,850USD£3,687GBP
- Report
- January 2026
- 194 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- August 2025
- 199 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- November 2025
- 405 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- January 2026
- 195 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 186 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 199 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- August 2025
- 195 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- September 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- January 2026
- 195 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 181 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- January 2026
- 185 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- October 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- April 2025
- 175 Pages
Global
From €3932EUR$4,490USD£3,413GBP

The Antimicrobial Susceptibility Testing (AST) market within the In Vitro Diagnostics (IVD) industry is a rapidly growing sector. AST is used to determine the effectiveness of antibiotics against a particular strain of bacteria, and is used to guide clinical decisions in the treatment of infectious diseases. AST tests are used to identify the most effective antibiotic for a particular infection, and to detect the emergence of antibiotic resistance. AST tests are used in both clinical and research settings, and are becoming increasingly important as antibiotic resistance continues to rise.
The AST market is driven by the increasing prevalence of infectious diseases, the growing demand for rapid and accurate diagnosis, and the need for personalized medicine. The market is further supported by the increasing adoption of automated systems, which reduce the time and cost associated with manual testing.
Notable companies in the AST market include bioMérieux, Becton Dickinson, Thermo Fisher Scientific, Bruker, and Hologic. Show Less Read more